It takes Rahul Garg’s toolkit to make an industrial goods platform a unicorn

It takes Rahul Garg’s toolkit to make an industrial goods platform a unicorn

Sensing the oncoming storm, Rahul Garg knew that India is heading towards trouble. Within a few weeks in April, Mr. Garg and his team at Moglix began working with manufacturers of oxygen concentrators in India, while also sending charter flights to China and Germany to procure the concentrators. Since then, the company has procured some 6,000 oxygen concentrators, which Moglix has been selling to corporate and industrial houses in India. They, in turn, have been giving them to their employees on a group-sharing model, based on a template developed by Garg and Moglix

“We have probably touched half a million lives through oxygen concentrators,”

Rahul says

Moglix, a company that Garg founded in 2015, is part of a consortium where 10 manufacturers have come together to ramp up oxygen concentrators to make India self-reliant in the segment.

“We are working with them on both the global and domestic supply chain on raw materials,” 

Rahul adds

Join our team at Moglix, India’s latest unicorn, and fastest-growing B2B marketplace

Join our team at Moglix, India’s latest unicorn, and fastest-growing B2B marketplace

Work where it matters! Join our team at Moglix, India’s largest and fastest-growing B2B marketplace, which now has joined the unicorn club. With close to 500,000+ SKUs, Moglix has a supply chain network of 16,000+ suppliers, 35+ warehouses, and logistics infrastructure, making its marketplace the largest eCommerce platform in the industrial goods category in India. If you’d like to be part of Moglix’s growth story, these job openings may be for you.

Moglix: How Rahul Garg built an unexpected unicorn

Moglix: How Rahul Garg built an unexpected unicorn

This fortnight, Forbes India has covered an inspiring story of Mr. Rahul Garg and his journey of building an unexpected unicorn. Six-year-old Moglix, which gets nearly 65 percent of its business from Tier II and III towns helps over 500,000 small & medium-sized businesses procure industrial goods. 

During the first wave, Moglix did its bit to supply PPE kits and N95 masks, and in the devastating second wave, it managed to procure some 6,000 oxygen concentrators; the startup reckons it has touched half a million lives through these devices. Of course, there’s more to Moglix than Covid-19 relief, deep-dive, into the fascinating story of this B2B venture that has raised $220 million in funding so far written by  Manu Balachandran, turn to page 24 of Forbes June’2021 edition.

Moglix becomes Latest Startup to Join the Unicorn Club

Moglix becomes Latest Startup to Join the Unicorn Club

Moglix, a B2B e-commerce platform for manufacturing goods, has raised $120 million as a part of its latest series E funding round, led by Falcon Edge Capital and Harvard Management Company (HMC), taking the overall valuation of the company to $1 billion.

Existing investors Tiger Global, Sequoia Capital India and Venture Highway also participated as part of this round.

This is almost a three-time jump in valuation for the company which had last raised $60 million in July 2019, at a valuation of $200 million-$300 million.

Read: Moglix launches supply chain finance platform Credlix

With the current equity infusion, the total funds raised till date by Moglix stands at $220 million.

“We started six years ago with a firm belief in the untapped potential of the Indian manufacturing sector. We are glad that Falcon Edge Capital and Harvard Management Company (HMC) have partnered with us in this journey. Falcon Edge, with its deep roots in the Middle East and Europe and an understanding of public companies will guide us through the next phase of our journey,”

said Rahul Garg, founder and chief executive officer, Moglix.

The six year old startup provides manufacturers with industrial goods through its e-commerce platform, and is building an operating system for manufacturing that provides its customers a full stack service covering procurement, packaging, supply chain financing and highly integrated software.

Startups fight COVID-19: Moglix fights against India’s oxygen crisis

Startups fight COVID-19: Moglix fights against India’s oxygen crisis

As India battles the deadly second wave of the COVID-19 pandemic, startups, corporates, and individuals are all rallying together to ensure that they are doing their bit. The biggest challenge in the second wave is the dearth of oxygen cylinders along with crucial medicines.

“We estimate the need for at least 100,000 oxygen concentrators across India. However, each person buying an oxygen concentrator for themselves is not scalable and will lead to inefficient distribution of precious resources. Most people will find the cost prohibitive and the requirement short-lived (one to two weeks),”

Rahul says.

B2B ecommerce startup Moglix has been supplying PPE, oxygen concentrators, oximeters, thermometers etc. to essential goods and services companies to ensure their employees are protected. It has also distributed 15 million+ PPE kits and safety items amid this pandemic.

The startup has developed a “group sharing model” for increasing the impact of every oxygen concentrator by 100x, and is enabling organisations, NGOs, trusts, and RWAs to create oxygen concentrator banks for patients and providing a safety net for their communities.

“If your organisation would like to join us in this mission to provide a safety network to corona warriors, please write to us at We can help you set up similar network-based models for your organisation and share our learning/ SOPs. Let us come together to do our bit in this fight,”

Rahul Adds.

‘The PLI scheme will facilitate bulk order generation for MSMEs’

Moglix Founder: The PLI scheme will facilitate ease of doing business for MSMEs.

‘The PLI scheme will facilitate bulk order generation for MSMEs’

The manufacturing supply chain in India is witnessing a rebound within a year of the announcement of the Productivity Linked Incentive scheme for 13 sub-sectors. Envisaged at an outlay of Rs 145,000 crores, the scheme is expected to recharge job growth and manufacturing output. It has already attracted investment proposals worth Rs 5100 crores in pharmaceuticals and another Rs 11000 crores in large-scale electronics manufacturing. These numbers reflect a robust takeoff for the scheme despite a very challenging business climate due to the pandemic.

Indian MSMEs have an array of opportunities to look forward to over the next five to seven years. The PLI scheme has an anchor-led model that will enable OEMs to adopt an import-substitution approach and thus shift towards greater collaboration with Indian MSMEs to plug them into the global manufacturing supply chain ecosystem.

Backward Linkages Will Pass-Through Incentives to MSMEs

The PLI scheme envisages an annual increment in sales of goods made in India and minimum capital investment caps as the two factors for identifying the beneficiaries. The uniqueness of the PLI scheme’s systemic design will nudge large OEMs towards local sourcing for greater “Made in India” capacity utilization of Indian MSMEs and foster strong OEM-MSME partnerships. The supply chain collaboration will ensure a pass-through of the 4-6 percent cost cushion to MSMEs in the short-term, helping them develop cost competitiveness in the long run.